Published on 3 Nov 2022 on Zacks via Yahoo Finance
Amryt Pharma PLC Sponsored ADR (AMYT) Reports Q3 Loss, Lags Revenue Estimates
Amryt Pharma PLC Sponsored ADR (AMYT) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to loss of $0.07 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of -50%. A quarter ago, it was expected that this company would post a loss of $0.04 per share when it actually produced a loss of $0.02, delivering a surprise of 50%.
Over the last four quarters, the company has surpassed consensus EPS estimates two times.